What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Breast cancer
Clifford A. Hudis mainly investigates Breast cancer, Internal medicine, Oncology, Cancer and Surgery.
His Breast cancer research is multidisciplinary, incorporating perspectives in Gynecology, Radiation therapy and MEDLINE.
His work in Internal medicine tackles topics such as Endocrinology which are related to areas like Aromatase and Mammary gland.
As part of the same scientific family, Clifford A. Hudis usually focuses on Oncology, concentrating on Clinical trial and intersecting with Patient participation.
The study incorporates disciplines such as Survival rate, Hazard ratio and Risk factor in addition to Cancer.
His Surgery research incorporates themes from Toxicity and Urology.
His most cited work include:
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (1828 citations)
- Trastuzumab — Mechanism of Action and Use in Clinical Practice (1812 citations)
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 (1248 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer and Chemotherapy.
His research links Surgery with Internal medicine.
The various areas that he examines in his Surgery study include Gastroenterology and Urology.
Clifford A. Hudis usually deals with Breast cancer and limits it to topics linked to Cyclophosphamide and Doxorubicin.
His studies deal with areas such as Stage, Bevacizumab, Disease and Taxane as well as Oncology.
Clifford A. Hudis has researched Cancer in several fields, including Survival rate, Risk factor and Pathology.
He most often published in these fields:
- Internal medicine (70.39%)
- Breast cancer (69.74%)
- Oncology (57.73%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (70.39%)
- Breast cancer (69.74%)
- Oncology (57.73%)
In recent papers he was focusing on the following fields of study:
Clifford A. Hudis spends much of his time researching Internal medicine, Breast cancer, Oncology, Cancer and Trastuzumab.
His research integrates issues of Surgery and Radiation therapy in his study of Breast cancer.
His Surgery research includes themes of Neoadjuvant therapy, Tolerability and Cohort.
His Oncology research is multidisciplinary, relying on both Letrozole, Gynecology and Clinical trial, Phases of clinical research.
His research in Cancer intersects with topics in Guideline, Medical physics, Randomized controlled trial and Surgical oncology.
His studies in Trastuzumab integrate themes in fields like Ejection fraction, Heart failure and Disease.
Between 2015 and 2021, his most popular works were:
- 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) (879 citations)
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial (820 citations)
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years (300 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Breast cancer
Clifford A. Hudis mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer and Surgery.
His Breast cancer study combines topics in areas such as Guideline and Cancer research.
As part of his studies on Internal medicine, he frequently links adjacent subjects like Alliance.
His work carried out in the field of Oncology brings together such families of science as Aromatase inhibitor, Metastatic breast cancer, Hormone receptor, Gynecology and Combination therapy.
His Cancer study incorporates themes from Surgical oncology, Adipokine, Pediatrics and Bioinformatics.
In his research, Chemoradiotherapy, Metastasis, Survival analysis, Retrospective cohort study and Log-rank test is intimately related to Cohort, which falls under the overarching field of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
